Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Arrowhead Pharmaceuticals Inc
Income to Minority Interest
Arrowhead Pharmaceuticals Inc
Income to Minority Interest Peer Comparison
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
Income to Minority Interest
$6.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
37%
|
|
Abbvie Inc
NYSE:ABBV
|
Income to Minority Interest
-$10m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Income to Minority Interest
$26m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
54%
|
CAGR 10-Years
4%
|
|
Amgen Inc
NASDAQ:AMGN
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Arrowhead Pharmaceuticals Inc's Income to Minority Interest?
Income to Minority Interest
6.7m
USD
Based on the financial report for Mar 31, 2024, Arrowhead Pharmaceuticals Inc's Income to Minority Interest amounts to 6.7m USD.
What is Arrowhead Pharmaceuticals Inc's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 10Y
37%
Over the last year, the Income to Minority Interest growth was 255%.